Correction to: Mesoporous bowl-shaped polydopamine co-loaded temozolomide and indocyanine green for synergistically inhibiting glioblastoma

Key Points

• Polydopamine is effective in co-loading temozolomide and indocyanine green for glioblastoma treatment, enhancing therapeutic outcomes.
• Key evidence shows that using this mesoporous structure can increase the bioavailability of the drugs, potentially improving efficacy.
• Analysis reveals enhanced synergistic effects when combining temozolomide with indocyanine green in mesoporous bowl-shaped carriers.
• This approach may enable better glioblastoma management but requires further validation in clinical settings.